Literature DB >> 6979245

Phenotypic heterogeneity of human T-cell malignancies: demonstration by monoclonal antibodies and cytochemical markers.

D M Knowles, J P Halper, G A Machin, P Byeff, R Mertelsman, L Chess.   

Abstract

The present study sought to delineate the phenotypic heterogeneity of the human T-cell malignancies. Twenty T-cell neoplasms were investigated for reactivity with the OKT hybridoma monoclonal antibodies and expression of acid alpha-naphthyl acetate esterase (ANAE), beta-glucuronidase (BG), and acid phosphatase (AP) activity. Twelve cases (Mycosis fungoides, Sezary syndrome, cutaneous T-cell lymphoma, chronic lymphocytic leukemia) were OKT3'T4', ie, expressed the phenotype commonly associated with mature T-helper cells. These cases were further divisible into ANAE+BG+ (6 cases), ANAE-BG+ (5 cases), and ANAE-BG- (1 case) phenotypes. In contrast to the 12 OKT3+T4+ cases, the remaining 8 cases showed considerable inter- and intratumor heterogeneity with respect to reactivity with the OKT antibodies. Six of these cases (acute lymphoblastic leukemia, lymphoblastic lymphoma) expressed phenotypes consistent with various intrathymic stages of T-cell differentiation. Five of the latter 6 cases were AP+BG+ANAE-, analogous to the majority of normal cortical thymocytes; an OKT3+T4-T8+T10+ neoplasm was ANAE+, analogous to normal medullary thymocytes. Two cases expressed the previously undescribed OKT3+T4-T8-T10+ phenotype. These studies demonstrate that the T-cell malignancies are divisible into phenotypes which correspond to normal maturational stages of T-cell differentiation and functionally distinct T-cell subsets. Phenotypic analysis of the human T-cell malignancies may provide a basis for understanding their biological heterogeneity and may aid in the identification of transitional stages of T-cell differentiation and minor T-cell subsets.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6979245     DOI: 10.1002/ajh.2830120305

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  4 in total

1.  Coincident change of cellular function and phenotype in the course of a suppressor T cell acute lymphocytic leukaemia.

Authors:  G Sieber; W D Ludwig; H Teichmann; F Herrmann; H Rühl
Journal:  Clin Exp Immunol       Date:  1985-06       Impact factor: 4.330

Review 2.  Cytochemistry of lymphoid cells: a review of findings in the normal and leukaemic state.

Authors:  A D Crockard
Journal:  Histochem J       Date:  1984-10

3.  Routine flow cytometric diagnosis of lymphoproliferative disorders.

Authors:  I G Barr; B H Toh
Journal:  J Clin Immunol       Date:  1983-04       Impact factor: 8.317

4.  Leu-M1 antigen expression in T-cell neoplasia.

Authors:  R Wieczorek; J S Burke; D M Knowles
Journal:  Am J Pathol       Date:  1985-12       Impact factor: 4.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.